Stratos Wealth Partners, LTD. - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 52 filers reported holding GALECTIN THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$77,664
+33.3%
40,4500.0%0.00%
+100.0%
Q2 2023$58,248
-31.4%
40,4500.0%0.00%
-50.0%
Q1 2023$84,945
+83.6%
40,450
-1.2%
0.00%
+100.0%
Q4 2022$46,274
-30.9%
40,9500.0%0.00%
-50.0%
Q3 2022$67,000
+24.1%
40,9500.0%0.00%
+100.0%
Q2 2022$54,000
-18.2%
40,9500.0%0.00%0.0%
Q1 2022$66,000
-22.4%
40,9500.0%0.00%
-50.0%
Q4 2021$85,000
-46.5%
40,9500.0%0.00%
-50.0%
Q3 2021$159,000
+21.4%
40,9500.0%0.00%
+33.3%
Q2 2021$131,000
+47.2%
40,9500.0%0.00%
+50.0%
Q1 2021$89,000
-3.3%
40,9500.0%0.00%
-33.3%
Q4 2020$92,000
-17.1%
40,950
-1.2%
0.00%
-25.0%
Q3 2020$111,000
-12.6%
41,4500.0%0.00%
-20.0%
Q2 2020$127,000
+56.8%
41,4500.0%0.01%
+25.0%
Q1 2020$81,000
-31.9%
41,4500.0%0.00%
-20.0%
Q4 2019$119,000
-21.7%
41,4500.0%0.01%
-28.6%
Q3 2019$152,000
-11.6%
41,4500.0%0.01%0.0%
Q2 2019$172,000
-17.7%
41,450
+1.2%
0.01%
-22.2%
Q1 2019$209,000
+49.3%
40,9500.0%0.01%
+28.6%
Q4 2018$140,000
-17.2%
40,950
+45.5%
0.01%
-12.5%
Q3 2018$169,000
-5.6%
28,1540.0%0.01%0.0%
Q2 2018$179,000
+34.6%
28,1540.0%0.01%
+33.3%
Q1 2018$133,000
+41.5%
28,1540.0%0.01%
+50.0%
Q4 2017$94,000
+56.7%
28,1540.0%0.00%
+33.3%
Q3 2017$60,000
+1.7%
28,154
+16.6%
0.00%0.0%
Q2 2017$59,000
+5.4%
24,1540.0%0.00%0.0%
Q1 2017$56,000
+133.3%
24,1540.0%0.00%
+200.0%
Q4 2016$24,000
-11.1%
24,1540.0%0.00%
-50.0%
Q3 2016$27,0000.0%24,154
+31.3%
0.00%0.0%
Q2 2016$27,000
+3.8%
18,4000.0%0.00%0.0%
Q1 2016$26,000
-13.3%
18,4000.0%0.00%
-33.3%
Q4 2015$30,000
+30.4%
18,400
+84.0%
0.00%0.0%
Q3 2015$23,000
-23.3%
10,000
-9.9%
0.00%
-25.0%
Q2 2015$30,000
-54.5%
11,100
-41.9%
0.00%
-50.0%
Q1 2015$66,0000.0%19,1000.0%0.01%
-33.3%
Q4 2014$66,000
-31.2%
19,1000.0%0.01%
-47.8%
Q3 2014$96,000
-46.7%
19,100
+48.1%
0.02%
-61.7%
Q2 2014$180,00012,9000.06%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders